LifeSci Acquisition II (LSAQ) News Today → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free LSAQ Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisSocial MediaStock AnalysisSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNew Providence Acquisition Corp II - Ordinary Shares - Class Amoney.usnews.com - December 7 at 4:47 AMSeaport Global Acquisition II Corp Units (1 Ord Class A & 1/2 War) SGIIU Stock Quotemorningstar.com - May 23 at 6:43 PMM3 Brigade Acquisition II Corp Ordinary Shares - Class Amorningstar.com - April 20 at 7:40 PMYankees' big deadline acquisition admits he wasn't healthy when traded to New Yorkfoxnews.com - March 11 at 4:24 PMWith SPAC deal done, Triangle science company hits public marketsfinance.yahoo.com - October 7 at 3:09 PMScience 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCEfinance.yahoo.com - October 7 at 10:09 AMOctober SPAC Merger Calendar: A Look At Upcoming Votes, Stocks To Watchmarkets.businessinsider.com - October 4 at 3:27 PMLifesci Acquisition II Corp (LSAQ)investing.com - July 24 at 12:16 AM Get LifeSci Acquisition II News Delivered to You Automatically Sign up to receive the latest news and ratings for LSAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> LSAQ Media Mentions By Week LSAQ Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LSAQ News Sentiment▼0.000.41▲Average Medical News Sentiment LSAQ News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LSAQ Articles This Week▼00▲LSAQ Articles Average Week Get LifeSci Acquisition II News Delivered to You Automatically Sign up to receive the latest news and ratings for LSAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BIAF News NOTV News SEPA News KZR News JUPW News AVRO News CLGN News ENZ News ICCM News VAXX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LSAQ) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeSci Acquisition II Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
